Promoting

Leading Exellence
& Innovation

Orion Pharma Ltd.

www.orionpharmabd.com
Corporate Profile 01

Orion Group
Corporate Profile 02

STATEMENT OF
THE CHAIRMAN

Our company started its journey with the

vision to become a world-class
pharmaceutical company in the field of
generic finished products, and we have
already been able to establish ourselves as
one of the most reliable brands in the
country.
Corporate Profile 03

corporate
Address

ORION HOUSE
153-154 Tejgaon Industrial Area,
Dhaka-1208, Bangladesh
Corporate Profile 04

Inrespect to the mission of Orion Group, it has kept it all same but made a change in the
chronological order and rearranged them according to their priorities.

VISION
To transform communities by blending
the mix of integrity, teamwork and
creativity of our people.

MISSION
Exceeding customer Satisfaction and
granting trust through services
Assuring quality products from
advanced manufacturing facilities
Introducing new and innovative prod-
ucts and technologies
Continuous development of people
competency
Recognizing individual contribution

VALUES
Values
Quality in everything we do
Transparent and fair in all our dealings
Take initiatives to exceed standards
Trust and respect to each other
World as a team
Share social responsibility
Corporate Profile 05

ABOUT
STRATEGIC BUSINESS UNITS

Pharma & Healthcare Cosmetics & Toiletries

Kohinoor Chemical Company (Bangladesh) Ltd.

Power & Energy Footwear & Footcare

Orion Footwear Ltd.

Home Appliances

Orion Home Appliances Ltd.

Infrastructure Development
Real Estate

Agro & Consumer Products City Centre Orion Properties Ltd.

Jafflong Tea Company Ltd.

Food & Beverage
Orion Tea Company Ltd. Panbo Bangla Mushroom Ltd.

Pristine Consumer Products Ltd.

Hospitality & Tourism Textiles & Garments

Orion Tourism & Entertainment Ltd. Orion Knit Textiles Ltd.

Corporate Profile 06

ABOUT
MILESTONE PROJECTS
The 11.8 km long “Mayor Mohammad Hanif Flyover” is the longest flyover and the first PPP
The LONGEST

project in the country on BOOT basis. This revolutionary and capital intensive project has been
flyover

operational for traffic since October 2013. It has been cited with commendation as a reference
project in the annual study paper of Asian Public Governance (APG) Forum on Public Private
Partnership (PPP) & International Public Procurement Forum in 2016 conference titled
“Ensuring Successful PPPs for Asia’s Development: Governance and Law.”
The FASTEST HFO

Two (2) 100 MW each HFO based power plants - Dutch Bangla Power & Associates Limited and
power plants

Orion Power Meghnaghat Limited at Siddhirganj and Meghnaghat, Narayanganj, respectively

were completed in a record time of just nine (9) months. The plants have been distributing
electricity to the national grid on regular basis since 2011 and the contract with BPDB to sell
electricity was renewed for five (5) more years till 2021.

The 37-storied “City Centre”; the tallest building in the country, is a commercial complex cum
The TALLEST
building

multistoried car parking at Motijheel, Dhaka. The landmark building is equipped with the most
modern firefighting equipment, automated car parking system, earthquake protection system,
and necessary amenities to re-define the working space.

Panbo Bangla Mushroom Limited is a 100% export-oriented prudent venture of Orion Group and
mushroom plant

carries out growing, processing and marketing of cultivated mushrooms. The health conscious
The BIGGEST

segment of the world population has started considering mushroom as one of their regular
diets. The key advantage which would help to thrive in an export-oriented mushroom industry
in Bangladesh is significant low labour cost. Panbo’s production of Baby Button Mushroom
(White Button Mushroom or Agaricous Bisporus) coupled with a rapidly growing global demand
would create a unique opportunity to step in the very prospective global agro industry.

Orion has been awarded to implement the first ever PPP Project in Tourism & Hospitality Sector of Bangladesh,
tourism complex

“Development of Tourism Resort and Entertainment Village” at Parjatan Holiday Complex, Cox’s Bazar. The
The LARGEST

concept design has been executed by Forrec Ltd. of Canada. The entertainment village would be first of its kind in
the country. This mega project incorporates multiple resorts (five-star and four-star) with diverse amenities
encompassing villa resort, spa hotel, water sports, water taxies, health & fitness center, multiple sports facility,
multiplex movie theatre, cultural show, food, beverage and retail, cultural walk promenade and a world class
full-fledged Theme Park with twenty nine (29) water and ground based rides and entertainment activities. This
Project would be the most giant leap forward in the tourism of Bangladesh for domestic and international tourists.

Orion Group is implementing one of the biggest Pharma Parks of the country and so far the
finest and most comprehensive pharmaceutical plant at Siddhirganj, Narayanganj where a
Pharma Park
The BIGGEST

complete array of pharmaceutical facilities and solutions will be incorporated within single
complex. This unique establishment has been designed to follow all latest global standards like
USFDA, UK MHRA, Health Canada, and Australian TGA. In addition to conventional pharma
products, the new plant will also incorporate state of the art technologies to manufacture
cephalosporin, biotech products, oncology, hormones drugs among others.

Orion Power Dhaka Limited (OPDL) is the largest single unit coal based Ultra Super-Critical power
based power plant
The LARGEST coal

plant in Bangladesh being implemented in Gozaria, Munshiganj under IPP basis with a net capacity of
630 MW (Gross 700 MW). Orion Group has adopted “Clean Coal Technology”, a collection of technolo-
gies including Flue Gas Desulphurization which has been developed to mitigate the environmental
impacts and ensure zero emission to the atmosphere. Similar to OPDL, Orion Power Unit -2 Dhaka
Limited is also one of the largest IPP based single unit coal based Ultra Super-Critical power plants
being implemented in Gozaria, Munshiganj with a net capacity of 635 MW (Gross 700 MW).
Corporate Profile 07

Overview
Orion Pharma Limited
Orion Pharma Limited (Orion Pharma/Company), previous name Orion Laboratories Limited, a company of
ORION GROUP, was incorporated in 1965; and owns and operates a modern pharmaceutical factory and
produces and sells pharmaceutical drugs and medicines. It also owns approximately 21.76% shares of
Orion Infusion Limited, a public company listed with Dhaka Stock Exchange and Chittagong Stock Exchange
since 1996, manufacturing and marketing intravenous fluids.

At present, the company has tablet, capsule, PFS, ampoule, cephalosporin injectables, cream and ointment
products of differnt therapeutic group. Its consolidated sales in 2012 is Tk. 9,546.32 million with a growth
of approximately 35.86% compared to 2011. The Company has a market share of around 2% of the phar-
maceuticals market of the country which is approximately Tk 90,000 million with 22% growth in 2012.

Orion Pharma Ltd. is one of the premier pharmaceutical companies of Bangladesh for manufacturing and
marketing branded-generic primary & chronic care medicines, maintaining strict compliance of WHO CGMP
standards. Given vast experiences of over four decades imbibed with advanced technical and professional
expertise, Orion Pharma now levers a wide array of therapeutic areas including life saving anticancer drugs
and injectables having more than 110 generics in 260 presentations.
Corporate Profile 08

Nature of Business : Manufacturing and Marketing of

Pharmaceutical Finished Products
No. of Generics : 100
No. of Therapeutic Group : 35
No. of dosage forms : 260
No. of Brands : 110

Available dosage forms

Tablet, Capsules, SR Tablet, Chewable Tablet, Injection (Ampoule & Vial), Lyophilized
Injection, Syrup, Suspension, Cream/Ointment
Corporate Profile 09

Orion Pharma Limited is dedicated to serving its valued customers with products of excellent quality,
through continuous improvement in process & technology, complying with the guidelines of Good Manu-
facturing Practices (GMP) and the requirements of ISO9001:2008 Quality Management System.

Orion Pharma is being awarded ISO 9001: 2008

Certified for Manufacturing & Selling Pharmaceuti-
cal Products for Orion Laboratories Ltd. (now Orion
Pharma Ltd.)

As a recognition of high standard Quality Assurance

using modern machinery, Orion has achieved the
recommendation of UNICEF as a "Potential Medi-
cine Supplier of UNICEF"
Corporate Profile 10

Antibiotics

Pharyngitis/Tonsillitis, Otitis media,

Sinusitis, Acute bronchitis

Lower respiratory tract infections,

abdominal pain, urinary tract infection,
fever
Establishing the
competitive
advantage through Septicemia, meningitis, Lower respiratory
infections, pneumonia
product strategy,
particularly
Building brand or Lower respiratory tract infections, Otitis
Vitamins & Minerals

flagship portfolio, Media, UTI, Gonorrhoea, Septicemia

is another category
of measuring the Acute Exacerbation of Chronic Bronchitis,
Impaired immune function, diarrhoea,
key performance of Acute Bacterial Sinusitis, Complicated
SSTI, Uncomplicated SSTI, Complicated
pneumonia, common cold, growth
retardation, loss of appetite
intellectual capital.
Intra-abdominal Infection, Diabetic Foot
Infection

As on June 30, Haematinics

2018, 19 products Antiulcerants
Fero en ®

are being recognized Iron Sucrose USP

100 mg/ 5 ml Infusion

as our flagship Rapid supply of iron in emergency

conditions such as anemic pregnant
Benign gastric and duodenal ulcers
products among 231 including those complicating NSAID
therapy, erosive reflux oesophagitis and
women, women of child bearing age
especially those with heavy menstrual

products.
loss, frequent blood donors
for disorders associated with
hypersecretion of gastric acid, such as the
Zollinger-Ellison syndrome.

Treatment of Gastroesophageal Reflux

Disease (GERD), Healing of erosive
esophagitis, Maintenance of healing of
erosive esophagitis, Symptomatic relief of
Gastroesophageal Reflux Disease (GERD),
Risk reduction of NSAID associated gastric
ulcer, H. pylorieradication (Triple therapy)
Corporate Profile 11

Antioxidants

Antacids & Antiflutulant

Coronary Heart Diseases, Stroke, Early
aging, Atherosclerosis, Diabetic mellitus,
Tumors and cancers

Establishing the Hyperacidity, gastric and duodenal ulcer,

Antihypertensives gastritis, heartburn, dyspepsia,
competitive gastroesophageal reflux. Novelta is also
indicated for the relief of flatulence,
advantage through abdominal distention and windy colic

product strategy, Congestive heart failure, essential

Antispasmodics
particularly
hypertension, edema, ascites due to liver
cirrhosis

Building brand or
flagship portfolio, Antithrombotics
Gastroenteritis, enterocolitis, diarrhea,
is another category cholecystitis, dysentery

of measuring the
Ischemic events, Myocardial Infarction,
key performance of Ischemic Stroke, Acute Coronary Bone modulating agent
Syndrome, Peripheral vascular diseases
intellectual capital.
As on June 30, Antihistamines
Prevention and treatment of osteoporosis
2018, 19 products both in women
postmenopausal) and men
(especially

are being recognized

as our flagship Seasonal and perennial allergic rhinitis,
such as sneezing, nasal discharge & Lipid lowering drugs
products among 231 itching, congestion/stuffiness, ocular
itching, tearing and redness, itching of

products.
palate and coughing

Diabetic or Cardiac patient with High

Anticancer Cholesterol level, any patients with High
Cholesterol level

NSAID
Philadeiphia chromosome positive
chronic myeloid leukemia in all 3 phases,
gastrointestinal stromal tumors

Low back pain, rheumatoid arthritis,

osteoarthritis, post-operative pain
Corporate Profile 12

Orion Pharma Limited

AROUND THE WORLD

Kosovo
Armenia
Nepal
Bhutan
Iraq
Sudan
Somaliland

Afghanistan
Fiji
Cambodia
Myanmar
Sri Lanka
Somalia
Lesotho
Corporate Profile 13

SOME SNAPSHOTS OF OUR

EFFORTS TO MAINTAIN EXTERNAL RELATIONSHIP

AGM 2017

Orion Pharma Limited held 52nd Annual General Meeting on December 14, 2018 at
Officers’ Club, 26, Baily Road, Ramna, Dhaka-1000, Bangladesh.

SOME SNAPSHOTS OF OUR

EFFORTS TO MAINTAIN INTERNAL RELATIONSHIP

STRATEGIC
CONFERENCE
2018

On January 18, 2018 the company arranged ‘Orion Pharma Limited Strategic Conference
2018’ at the beautiful location of BRAC CDM, Rajendrapur, Gazipur.
Corporate Profile 14

TRAINING &
DEVELOPMENT During financial year 2017-18, Orion Pharma Ltd. provided many trainings to the employ-
ees; both in-house and external.

Orion Pharma Ltd. has been maintaining its substantial growth in the pharmaceuticals
market through continuous improvement in technology and manpower. A group of highly
qualified skilled professional contributes their talent to equip people with necessary knowl-
edge and attitudes to meet the organization's needs in relation to its goal.

We always believe Training is not a privilege to be granted, but should be invested to the
employee according to their needs. Each training program was carefully designed and
sequentially executed after a critical Training Need Assessment analysis considering jobs
and job related task.

MSD
PROGRAM

The Medical Service Department at Orion Pharma Limited carried out many programs in the
financial year 2017-18 which included organizing Scientific Seminars, Round Table Meetings,
Rural Promotional Campaigns, Intern Doctors Reception Programs and many more.
Corporate Profile 15

Human Resource

Human Resource Development in Practice

Human Resource practices in ORION mostly dispersed with the tasks of assessing, anticipating and exploring knowl-
edge, skills and performance requirements of the organization and initiating actions to accomplish the objectives by
sourcing, deploying and retaining them. In course of time, if the organization as a whole or one of its subsystem fails
to perform up to the benchmark and remains in declining approaches, immediate intermediates are always being
ascertained and appreciated to regain and progress further with its Human Resources.

Hence, ORION recognizes and also cares for introducing and practicing policies being extremely cautious towards
human rights, employee motivations and other aspects that have impact in internal and external environments.
Through the entire process, ORION comes up with constantly developing HR planning.

Since employee satisfaction is one of the principle objectives of ORION, it emphasizes most in making everyone as one
of the key member of ORION family rather then introducing them as key members of a renowned business house.

Working Environment
From HR perspective in Bangladesh, now-a-days, other than monetary and other benefits/ facilities working environ-
ment is being treated as one of the key indicator to employee satisfaction. , which is mostly resolute by individual
approach and organization culture.

Apart from theoretically accepted key factors of good working environment, ORION pays utmost attention in developing
professional attitudes, individual developments in regard to knowledge, skills, culture, value, livelihood etc by dispos-
ing training sessions both on the job and from outsourced reputed training house nationally and internationally.
Corporate Profile SOCIAL & RELATIONSHIP CAPITAL 16
Establishing the comAll the CSR activities
mentioned below over here occur in three Our social and relationship capital focuses on strengthening our
levels: relationship with potential stakeholders. We also believe that the
very reason of our existence is to do much more than making money
• CSR activities undertaken by Orion
Pharma Limited
– solving social and environmental problems.
• CSR activities undertaken by its Orion Pharma Limited always gives With a view to supporting social
subsidiaries and utmost importance to the social causes, improving community
• CSR activities undertaken by Orion Group capital. We believe that being a well-being, and/or protecting the
Education: socially responsible business environment, OPL has been involved
Scholarship for Medical Students organization not only provides in various types of societal activities
Every year Orion Pharma Limited organizes sustainable business models, but also as our corporate social responsibility
a ceremony and invites the top medical has improved marketing, human over a long period of time. Corporate
students from different Government resource, employee satisfaction, social responsibility allows us to do
Medical Colleges all over Bangladesh to customer loyalty and brand our bit for the society, environment,
reward them with scholarships. From the perception. Concentrating on social customers and other relevant
very beginning, the company has decided to capital simultaneously helps to satisfy stakeholders.
be with those brilliant students of the the demand of potential stakeholders
We at OPL feel that we have a
country who cannot afford the exorbitant accordingly.
responsibility not only towards the
cost of medical education, by offering them Our overall business operation stands society but also our employees. We
scholarship and helping them become on the idea that businesses should not promote social responsibility in the
doctors. only be striving to make money but workplace as it builds a positive
On May 10, 2018 an inauguration ceremony should also bring benefits to the environment for our employees. We
of ‘Orion Medical Scholarship’ was society. Therefore, our main focus has also believe that it will provide us long
inaugurated at our Head Office - Orion been to develop and operate a term growth and success by building
House. The occasion was graced by Mrs. business which has a positive impact a warm image of the entity, which is a
Arzuda Karim, Director and Mr. Salman on the society as well as on the reflection of the mind-set of the
Obaidul Karim, Managing Director of the ecosystem. owners of the company.
company.
On this year’s program, a total of seven (7)
meritorious students were selected for this
scholarship. They expressed their gratitude
towards Orion and praised its endeavor to
help underprivileged students achieve their
dreams of becoming doctors. A total twenty
(20) students are being served with under
this program.
The program was ended with wise and
motivating words from Mrs. Arzuda Karim
and Mr. Salman Obaidul Karim. All of them
urged the students to study well and when
in future they will indeed become doctors,
they must also try to help out other
disadvantaged students achieve their
dreams of becoming a doctor.petitive
advantage through product strategy,
particularly Building brand or flagship
portfolio, is another category of measuring
the key performance of intellectual capital.
As on June 30, 2018, 19 products are being
recognized as our flagship products among
231 products.
Corporate Profile 17

ORION
MEDICAL JOURNAL

The Orion Medical Journal is a publication of Orion Pharma Limited. The Medical Service Department of OPL is
responsible for publishing Medical Journal quarterly in a year. The main purpose of the journal is to approach our
fraternity in medical profession with the latest developments in the fields of medical practice and research.1st
inaugural issue was in September,1998. We have an International Standard Serial Number (ISSN) which is an
eight-digit serial number used to uniquely identify a serial publication. Orion Medical Journal ISSN 1606-9722. In
Pharmaceuticals industries Orion Medical Journal is very much accepted by the Doctors society from its first
publication in 1998 and the following years. Many renowned Doctors has been involved with our publication as an
editorial and Authors. OPL has a strong image among doctors society that shows, we are not only focusing in
commercial purpose but also contributing in academic field.
Corporate Profile OUR PRODUCT INDEX 18

Therapeutic area Trade Name Generic Name Therapeutic class Indications

Acute bacterial sinusitis, Acute

Fluoroquinolone bacterial exacerbation of
Ataq Tab Gatifloxacin
antibiotic chronic bronchitis, pneumonia,
Skin Infections
Axet 125 Tab
Axet 250 Tab
2 nd generation
Axet 500 Tab Cefuroxime Axetil
cephalosporin Pharyngitis/Tonsillitis, Otitis
Axet 70 ml PFS
media, Sinusitis, Acute
Axet 750 IV/IM bronchitis
Co-Axet 250 Tab 2 nd generation
Cefuroxime Axetil +
cephalosporin with
Co-Axet 500 Tab Clavulanic Acid
beta lactamse inhibitor
Lower Respiratory Tract
3 rd generation Infections, Lower Abdominal
Cefditor 200 Tab Cefditoren
Cephalosporin Pain, Urinary Tract Infections,
Fever
Azalid 250 Cap
Azalid 500 Tab Upper respiratory tract
Azalid 15 ml PFS Azithromycin infections, Lower respiratory
Azalid 35 ml Susp tract infections, STD
Azalid 50 ml PFS Macrolide Antibiotic
Mac 100 ml PFS Respiratory tract infections ,
Mac DS PFS 100 Skin and skin structure
Erythromycin
ml infections, Pertussis (whooping
Mac DS PFS 70 ml cough)
Magnova 500 mg
IV/IM Inj Moderate to severe
Magnova 1 gm 4 th generation Pneumonia, Uncomplicated and
Cefepime
IV/IM Inj cephalosporin Complicated UTI,
Magnova 2 gm IV Uncomplicated Skin Infections
ANTIBIOTICS Inj
Maprocin 500 Tab Urinary tract infections, Lower
Maprocin 750 Tab 2 nd generation respiratory infections, Infectious
Ciprofloxacin
Maprocin 60 ml Fluoroquinolone diarrhea, Typhoid fever (enteric
Susp fever).
Septicemia, meningitis , Lower
Meromax 500 mg &
Meropenem Carbapenem respiratory infections,
1 gm IV
pneumonia
Treatment of susceptible
Sulfamethoxazole infections, Meningitis caused by
Octrim Susp Antibacterial
and trimethoprim Listeria, Treatment of
Pneumocystis jirovecii
Bronchitis, pneumonia,
Tetracycline Group of
Oriodox Cap Doxycycline sinusitis, cystitis, arthritis,
Drugs
acne
Acute bacterial exacerbation of
Gemifloxacin 4 th generation chronic bronchitis, mild to
Xemi Tab
Mesylate Fluoroquinolone moderate community acquired
pneumonia
Acute bacterial sinusitis, Acute
3 rd generation bacterial exacerbation of
Orlev 500 Tab Levofloxacin
Fluoroquinolone chronic bronchitis, pneumonia,
Skin Infections
Acute Exacerbation of Chronic
Bronchitis, Acute Bacterial
Sinusitis, Complicated SSTI,
Maximox 400 mg 4th generation
Moxifloxacin Uncomplicated SSTI,
Tab Fluoroquinolone
Complicated Intra-abdominal
Infection, Diabetic Foot
Infection
Pedicef 15 ml 3 rd generation Pharyngitis and/or tonsillitis,
Cefpodoxime
Drops Cephalosporin Community-acquired
Corporate Profile 19

Therapeutic area Trade Name Generic Name Therapeutic class Indications

pneumonia, Acute bacterial

Pedicef DS 50 ml
exacerbation of chronic
PFS
bronchitis
Sefin 250 Cap
Sefin 500 Cap
Sefin 250 IV/IM
Sefin 500 IV/IM Respiratory tract infections,
Sefin 1 gm IV/IM 1 st generation Skin and skin structure
Cephradine
Sefin 100 ml PFS Cephalosporin infections, Urinary tract
Sefin P. Drops infections
Sefin DS 50 ml PFS
Sefin DS 100 ml
PFS
Torped 250 IV/IM Lower respiratory tract
infections, Genitourinary
Torped 500 IV/IM Cefotaxime infections, Gynecologic
infections, Central nervous
Torped 1 gm IV/IM
system infections
Truso 200 Cap
Truso 400 Cap Uncomplicated urinary tract
infections, otitis media,
Truso Susp 37.5 ml
Cefixime pharyngitis and tonsillitis, acute
Truso Susp 50 ml 3 rd generation exacerbations of chronic
Truso 50 ml DS Cephalosporin bronchitis
Truso 15 ml PD
Vertex 250 IV
Vertex 250 IM
Vertex 500 IM Lower respiratory tract
Vertex 500 IV Ceftriaxon infections, Otitis Media, UTI,
Vertex 1 gm IM Gonorrhoea, Septicemia
Vertex 1 gm IV
Vertex 2 gm IV
2 nd generation Otitis media, Lower Respiratory
Xclor 100 ml PFS Cefaclor
cephalosporin Tract Infections
Xindal-150 Skin & Skin structure infection,
Clindamycin lincosamide antibiotic RTI, Septicemia, Intra
Xindal-300
abdominal Infections
Zidim 250 IV/IM Lower Respiratory Tract
Zidim 500 IV/IM Infections, Skin and Skin-
3rd generation
Ceftazidim Structure Infections, Urinary
Cephalosporin
Zidim 1gm IV/IM Tract Infections, Bacterial
Septicemia
Conaz 50 Cap Vaginal candidiasis, mucosal
ANTIFUNGALS Conaz 150 Cap
Fluconazole Azole antifungals candidal infections, systemic
candidiasis
Nidazyl 400 Tab Trichomoniasis, Amebiasis,
Nitroimidazole
Metronidazole Anaerobic bacterial infections,
Nidazyl Susp. Antimicrobial
Intra-abdominal infections
ANTIPROTOZOAL Zoana PFS 32ml
broad-spectrum Diarrhea caused by protozoa,
Zoana PFS 62ml Nitazoxanide
antiparasitic & Antiviral Amoebiasis, Helminth Infection
Zoana Tab
Dermatophytosis, Superficial
Econazole Nitrate
mycosis, Cutaneous
Avison Cream BP + Triamcinolone Antifungal
candidiasis, Ringworm,
Acetonide
Eczematous mycosis
TOPICAL Miki-H Cream
Miconazole Nitrate
BP + Hydrocortisone Topical Steroid
Intertrigo, Infected eczema,
moist & dry eczema , atopic
PREPERATION BP eczema, primary irritant
Fusidic Acid+ Atopic eczema, discoid
Topical corticosteroid
Xzema Cream Betamethasone eczema, Stasis eczema,
with antibacterial agent
Valerate psoriasis
Xenocort Ointment Clobetasol Topical Steroid Hyperacute eczema, chronic
Corporate Profile 20

Therapeutic area Trade Name Generic Name Therapeutic class Indications

P ro p io na te B P h y p e r k e r a t o t ic e c z e m a , c h r o n ic
Xenocort Cream hyperkeratotic psoriasis, acute
light sensitivity
Coronary Heart Diseases,
ANTIOXIDANTS EC-Plus Tab Vit. E + Vit. C Antioxidant/Vitamins
Stroke, Early aging,
Atherosclerosis, Diabetic
mellitus, Tumors and cancers
Beta Blocker +
Betacal Tab Atenolol + Amlodipin Calcium Channel
Blocker
Bisoloc 2.5
Bisoprolol Fumarate Beta Blocker Hypertension, Angina
Bisoloc 5
Calcium Channel
CCB -5 Tab Amlodipine
Blocker
Lopres 50 Tab Atenolol Beta Blocker
ANTIHYPERTENSIVE Frulac Tab Congestive Heart Failure,
Spironolactone + Antimineralocorticoid + Essential Hypertension,
Frulac 40 Tab Frusemide Loop diuretic Edema, Ascites due to liver
cirrhosis
Losan 25 Tab
Angiotensin 2 Receptor
Losan 50 Tab Losartan Potassium
Blocker
Losan 100 Tab Hypertension, Heart Failure
Losartan Potassium Angiotensin 2 Receptor
Losan Plus Tab
+ Hydrchlorthiazide Blocker + Thiazide
Peroxisome
Hyperlipidemia of types IIa, Iib,
Fenocap Cap Fenofibrate Proliferator Receptor
III & IV
alpha Agonist
Lipex 10 Tab Ensure better lipid management
LIPID LOWERING Lipex 20 Tab
Atorvastain Calcium 2 nd generation Statin with higher strength,
Dyslipidemia
DRUGS Rovex 5 Diabetic or Cardiac patient with
rd High Cholesterol level, Any
Rosuvastatin 3 Generation Statin
Rovex 10 patients with High Cholesterol
level
P2Y12 Platelet
Clognil 75 Tab Clopidogrel
Inhibitor Ischemic events, Myocardial
ANTITHROMBOTICS Clognil Plus Tab Clopidogrel + Aspirin
P2Y12 Platelet
Inhibitor + NSAIDs
Infarction, Ischemic Stroke,
Acute Coronary Syndrome,
Opagrel-5 Tab P2Y12 Platelet Peripheral vascular diseases
Prasugrel
Opagrel-10 Tab Inhibitor
Trimetazidine
Angimet Tab Dihydrochloride INN
20
Cytoprotective anti- Angina, Myocardial Infarction,
Trimetazidine
ANTIANGINALS Angimet MR Tab
Dihydrochloride BP
ischemic agent Heart Failure
Modified Release
Tablet
Angina, Heart Failure,
Nitrocap Cap Nitroglycerin USP Vasodialator
Pulmonary Hypertension
Oclazid Tab Gliclazide Treatment of maturity -onset
stable diabetics when dietary
Sulfonylureas
Oclazid MR Tab Gliclazide MR modification has failed to
control hyperglycemia
Ormin 500 Tab As monotherapy, as an adjunct
to diet to lower blood glucose in
ANTIDIABETICS Metformin
Hydrochloride
Biguanides patients with NIDDM, as
Ormin 850 Tab adjunct therapy for IDDM with
insulin
Stimulin 1 Tab As an adjunct to diet and
exercise for the management of
Glimepiride Sulfonylureas
Stimulin 2 Tab Type-2 diabetics, patients
whose hyperglycemia cannot
Corporate Profile 21

Therapeutic area Trade Name Generic Name Therapeutic class Indications

controlled by diet and exercise

alone
Calcium deficiency,
Maxical Tab Calcium 500 mg Mineral
Osteoporosis
Pre & post-operative treatment
when requirements are
Combivit IV/IM Inj Vitamin B Complex Vitamin increased as in fever, severe
burns, deficiency of Vitamin-B
complex, Healing wounds
For the prevention & treatment
Goldage Tab of vitamins and mineral
deficiencies
Multivitamin + Multivitamin +
For the prevention & treatment
Multimineral Multimineral
of vitamins and mineral
Silvage Tab
deficiencies for patients over 45
age
For the prevention & treatment
of vitamins and mineral
Multivitamin with cod
Gold Kid Vitamin deficiencies, children with
liver oil
increased requirement for
vitamins
Prevent low blood levels of iron
Glory Capsule Carbonyl Iron ph Mineral
during anemia or pregnancy)
Iron,Folic Acid, B-
For the treatment of iron &
Heptamin Cap Vitamins & C- Vitamin + Mineral
vitamin deficiencies
Vitamin
Scurvy, common cold,
influenza, gingivitis, wound
Livit-C Ascorbic Acid Vitamin
healing, maintaining healthy
blood vessels
Osteoporosis, rickets,
VITAMINS & Calcium + Vitamin
osteomalacia & tetany,
Maxical D Tab Vitamin + Mineral supplements during pregnancy
MINERALS D3
& lactation, Calcium & Vitamin
D deficiency
Osteoporosis, Softening of
Calcium + Vitamin C
bone, supplement in
Maxical M + Vitamin E + Vitamin + Multimineral
pregnancy, maintaining strong
Multimineral
& healthy bone
Calcium supplement during
Calcium 600 mg + pregnancy, osteoporosis,
Maxical DX Calcium Supplement
Vit D3 400 IU calcium deficiency,
osteoarthritis
Provide vitamins and minerals
throughout the pregnancy &
Multivitamin + Multivitamin +
Newage Tab during postnatal period for both
Multimineral Multimineral
lactating and non-lactating
mothers
Orioplex Tab Vitamin B Complex Vitamin B Complex
Multivitamins + Multivitamins +
Orioplex-M Tab
Minerals Minerals
Orioplex 100 ml Vitamin B deficiency
Syp
Vitamin B Complex Vitamin B Complex
Orioplex 200 ml
Syp
Thiamine Metabolic disorders, Thiamine
Tone Vitamin B1
hydrochloride deficiency
Iron+Zinc+Vit B-
Zimplex Syp Vitamin & Mineral Iron & vitamin deficiency
Complex
Pep Syp Impaired immune function,
Pep-2 100 ml Syp Zinc Zinc diarrhoea, pneumonia, common
Pep-2 200 ml Syp cold, growth retardation, loss of
Corporate Profile 22

haematinics

nsaid
Corporate Profile 23

muscle
relaxants

anti-dementia

anxiolytics &
antidepressant

antipsychotics

nerve
regenerating
agent

anti-
neuropathics
Corporate Profile 24

pde5 inhibitors

antihistamines

antiasthmatics

anti-coughs
Corporate Profile 25

anticancer

drug for urinary

retention

antacids

antiulcerants

laxatives
Corporate Profile 26

antiflatulent

gastroprokinetics

antispasmodics

bone
modulating
agent

anti-emetics

anti-gout
anti-fibrinolytic

opoid
analgesic
Corporate Profile 27

Bottle Washing
Machine

Capsule Filling Blister Machine

Machine

Liquid Manufacturing Water Granulation Suite

Vessel Treatment Plant

Effluent Treatment Corridor of

Plant Production Floor

Entrance of Production
Building R&D Lab

QC Lab

SOME
SNAPSHOTS OF OUR
PHARMA PARK
Corporate Profile 28

KEY
FACTS & FIGURES

We are now
ISO 9001: 2015 certified company

We have started export to Somaliland, total 11 inter-

national markets

We have introduced offering term life insurance as

employee benefit scheme

Net Revenue BDT 10,423.10 million

Gross Profit BDT 2,376.20 million
Net Profit BDT 801.76 million
Earnings Per Share BDT 3.43
Cash Dividend Per Share BDT 1.5

www.orionpharmabd.com